TY - STD TI - Taskar VS. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc. 2006;3:293–8. ID - ref1 ER - TY - JOUR AU - Spira, A. AU - Beane, J. AU - Shah, V. AU - Liu, G. AU - Schembri, F. AU - Yang, X. PY - 2004 DA - 2004// TI - Effects of cigarette smoke on the human airway epithelial cell transcriptome JO - Proc Natl Acad Sci VL - 101 UR - https://doi.org/10.1073/pnas.0401422101 DO - 10.1073/pnas.0401422101 ID - Spira2004 ER - TY - JOUR AU - Taskar, V. AU - Coultas, D. PY - 2008 DA - 2008// TI - Exposures and idiopathic lung disease JO - Semin Respir Crit Care Med VL - 29 UR - https://doi.org/10.1055/s-0028-1101277 DO - 10.1055/s-0028-1101277 ID - Taskar2008 ER - TY - JOUR AU - Chioma, O. S. AU - Drake, W. P. PY - 2017 DA - 2017// TI - Role of microbial agents in pulmonary fibrosis JO - Yale J Biol Med VL - 90 ID - Chioma2017 ER - TY - JOUR AU - Han, M. L. K. AU - Zhou, Y. AU - Murray, S. AU - Tayob, N. AU - Noth, I. AU - Lama, V. N. PY - 2014 DA - 2014// TI - Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Lancet JO - Respir Med VL - 2 ID - Han2014 ER - TY - JOUR AU - Molyneaux, P. L. AU - Cox, M. J. AU - Willis-Owen, S. A. G. AU - Mallia, P. AU - Russell, K. E. AU - Russell, A. M. PY - 2014 DA - 2014// TI - The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 190 UR - https://doi.org/10.1164/rccm.201403-0541OC DO - 10.1164/rccm.201403-0541OC ID - Molyneaux2014 ER - TY - JOUR AU - Huang, Y. AU - Ma, S. -. F. AU - Espindola, M. S. AU - Vij, R. AU - Oldham, J. M. AU - Huffnagle, G. B. PY - 2017 DA - 2017// TI - Microbes are associated with host innate immune response in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 196 UR - https://doi.org/10.1164/rccm.201607-1525OC DO - 10.1164/rccm.201607-1525OC ID - Huang2017 ER - TY - JOUR AU - Molyneaux, P. L. AU - Maher, T. M. PY - 2013 DA - 2013// TI - The role of infection in the pathogenesis of idiopathic pulmonary fibrosis JO - Eur Respir Rev VL - 22 UR - https://doi.org/10.1183/09059180.00000713 DO - 10.1183/09059180.00000713 ID - Molyneaux2013 ER - TY - JOUR AU - Wilson, E. C. F. AU - Shulgina, L. AU - Cahn, A. P. AU - Chilvers, E. R. AU - Parfrey, H. AU - Clark, A. B. PY - 2014 DA - 2014// TI - Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: an economic evaluation alongside a randomised controlled trial JO - PharmacoEconomics VL - 32 UR - https://doi.org/10.1007/s40273-013-0112-z DO - 10.1007/s40273-013-0112-z ID - Wilson2014 ER - TY - STD TI - Schwartz DA. Idiopathic pulmonary fibrosis is a complex genetic disorder. Trans Am Clin Clim Assoc. 2016;127:34–45. ID - ref10 ER - TY - JOUR AU - Kropski, J. A. AU - Blackwell, T. S. AU - Loyd, J. E. PY - 2015 DA - 2015// TI - The genetic basis of idiopathic pulmonary fibrosis JO - Eur Respir J VL - 45 UR - https://doi.org/10.1183/09031936.00163814 DO - 10.1183/09031936.00163814 ID - Kropski2015 ER - TY - STD TI - Armanios MY, Chen JJ-L, Cogan JD, Alder JK, Ingersoll RG, Markin C, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med. 2007 [cited 2017 Jul 17];356:1317–1326. ID - ref12 ER - TY - JOUR AU - Nogee, L. M. AU - Dunbar, A. E. AU - Wert, S. E. AU - Askin, F. AU - Hamvas, A. AU - Whitsett, J. A. PY - 2001 DA - 2001// TI - A mutation in the surfactant protein C gene associated with familial interstitial lung disease JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200102223440805 DO - 10.1056/NEJM200102223440805 ID - Nogee2001 ER - TY - JOUR AU - Cronkhite, J. T. AU - Xing, C. AU - Raghu, G. AU - Chin, K. M. AU - Torres, F. AU - Rosenblatt, R. L. PY - 2008 DA - 2008// TI - Telomere shortening in familial and sporadic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 178 UR - https://doi.org/10.1164/rccm.200804-550OC DO - 10.1164/rccm.200804-550OC ID - Cronkhite2008 ER - TY - JOUR AU - Noth, I. AU - Zhang, Y. AU - Ma, S. -. F. AU - Flores, C. AU - Barber, M. AU - Huang, Y. PY - 2013 DA - 2013// TI - Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(13)70045-6 DO - 10.1016/S2213-2600(13)70045-6 ID - Noth2013 ER - TY - JOUR AU - Fingerlin, T. E. AU - Murphy, E. AU - Zhang, W. AU - Peljto, A. L. AU - Kevin, K. AU - Steele, M. P. PY - 2013 DA - 2013// TI - Loci for pulmonary fibrosis JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2609 DO - 10.1038/ng.2609 ID - Fingerlin2013 ER - TY - JOUR AU - Hunninghake, G. M. AU - Hatabu, H. AU - Okajima, Y. AU - Gao, W. AU - Dupuis, J. AU - Latourelle, J. C. PY - 2013 DA - 2013// TI - MUC5B promoter polymorphism and interstitial lung abnormalities JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1216076 DO - 10.1056/NEJMoa1216076 ID - Hunninghake2013 ER - TY - JOUR AU - Seibold, M. A. AU - Wise, A. L. AU - Speer, M. C. AU - Steele, M. P. AU - Brown, K. K. AU - Loyd, J. E. PY - 2011 DA - 2011// TI - A common MUC5B promoter polymorphism and pulmonary fibrosis JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1013660 DO - 10.1056/NEJMoa1013660 ID - Seibold2011 ER - TY - JOUR AU - Roy, M. G. AU - Livraghi-Butrico, A. AU - Fletcher, A. A. AU - McElwee, M. M. AU - Evans, S. E. AU - Boerner, R. M. PY - 2014 DA - 2014// TI - Muc5b is required for airway defence JO - Nature VL - 505 UR - https://doi.org/10.1038/nature12807 DO - 10.1038/nature12807 ID - Roy2014 ER - TY - JOUR AU - Peljto, A. L. AU - Zhang, Y. AU - Fingerlin, T. E. AU - Ma, S. -. F. AU - Garcia, J. G. N. AU - Richards, T. J. PY - 2013 DA - 2013// TI - Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis JO - JAMA VL - 309 UR - https://doi.org/10.1001/jama.2013.5827 DO - 10.1001/jama.2013.5827 ID - Peljto2013 ER - TY - JOUR AU - Egger, G. AU - Liang, G. AU - Aparicio, A. AU - Jones, P. A. PY - 2004 DA - 2004// TI - Epigenetics in human disease and prospects for epigenetic therapy JO - Nature VL - 429 UR - https://doi.org/10.1038/nature02625 DO - 10.1038/nature02625 ID - Egger2004 ER - TY - STD TI - Yang IV, Schwartz DA. Epigenetics of idiopathic pulmonary fibrosis. Transl Res. 2015;165:48–60. ID - ref22 ER - TY - JOUR AU - Dakhlallah, D. AU - Batte, K. AU - Wang, Y. AU - Cantemir-Stone, C. Z. AU - Yan, P. AU - Nuovo, G. PY - 2013 DA - 2013// TI - Epigenetic regulation of mir-17∼92 contributes to the pathogenesis of pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 187 UR - https://doi.org/10.1164/rccm.201205-0888OC DO - 10.1164/rccm.201205-0888OC ID - Dakhlallah2013 ER - TY - JOUR AU - Issa, J. PY - 2014 DA - 2014// TI - Aging and Epigeneric drift: a vicious cycle JO - J Clin Invest VL - 124 UR - https://doi.org/10.1172/JCI69735 DO - 10.1172/JCI69735 ID - Issa2014 ER - TY - JOUR AU - Yang, I. V. AU - Pedersen, B. S. AU - Rabinovich, E. AU - Hennessy, C. E. AU - Davidson, E. J. AU - Murphy, E. PY - 2014 DA - 2014// TI - Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 190 UR - https://doi.org/10.1164/rccm.201408-1452OC DO - 10.1164/rccm.201408-1452OC ID - Yang2014 ER - TY - JOUR AU - Kidd, C. AU - Hayden, B. Y. PY - 2015 DA - 2015// TI - The psychology and neuroscience of curiosity Celeste JO - Neuron VL - 88 UR - https://doi.org/10.1016/j.neuron.2015.09.010 DO - 10.1016/j.neuron.2015.09.010 ID - Kidd2015 ER - TY - JOUR AU - Liu, F. AU - Killian, J. K. AU - Yang, M. AU - Walker, R. L. AU - Hong, J. A. AU - Zhang, M. PY - 2010 DA - 2010// TI - Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.129 DO - 10.1038/onc.2010.129 ID - Liu2010 ER - TY - JOUR AU - Fell, C. D. AU - Martinez, F. J. AU - Liu, L. X. AU - Murray, S. AU - Han, M. L. K. AU - Kazerooni, E. A. PY - 2010 DA - 2010// TI - Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 181 UR - https://doi.org/10.1164/rccm.200906-0959OC DO - 10.1164/rccm.200906-0959OC ID - Fell2010 ER - TY - STD TI - López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013;153(6):1194–217. ID - ref29 ER - TY - JOUR AU - Xu, J. AU - Gonzalez, E. T. AU - Iyer, S. S. AU - Mac, V. AU - Mora, A. L. AU - Sutliff, R. L. PY - 2009 DA - 2009// TI - Use of senescence-accelerated mouse model in Bleomycin-induced lung injury suggests that bone marrow – derived cells can Alter the outcome of lung injury in aged mice JO - J Gerontol A Biol Sci Med Sci VL - 64 UR - https://doi.org/10.1093/gerona/glp040 DO - 10.1093/gerona/glp040 ID - Xu2009 ER - TY - JOUR AU - Huang, W. T. AU - Akhter, H. AU - Jiang, C. AU - MacEwen, M. AU - Ding, Q. AU - Antony, V. PY - 2015 DA - 2015// TI - Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis JO - Exp Gerontol VL - 61 UR - https://doi.org/10.1016/j.exger.2014.11.018 DO - 10.1016/j.exger.2014.11.018 ID - Huang2015 ER - TY - JOUR AU - Richeldi, L. AU - Collard, H. R. AU - Jones, M. G. PY - 2017 DA - 2017// TI - Idiopathic pulmonary fibrosis JO - Lancet VL - 389 UR - https://doi.org/10.1016/S0140-6736(17)30866-8 DO - 10.1016/S0140-6736(17)30866-8 ID - Richeldi2017 ER - TY - JOUR AU - Liu, Y. -. M. AU - Nepali, K. AU - Liou, J. -. P. PY - 2017 DA - 2017// TI - Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets JO - J Med Chem VL - 60 UR - https://doi.org/10.1021/acs.jmedchem.6b00935 DO - 10.1021/acs.jmedchem.6b00935 ID - Liu2017 ER - TY - JOUR AU - Betensley, A. AU - Sharif, R. AU - Karamichos, D. PY - 2016 DA - 2016// TI - A systematic review of the role of dysfunctional wound healing in the pathogenesis and treatment of idiopathic pulmonary fibrosis JO - J Clin Med VL - 6 UR - https://doi.org/10.3390/jcm6010002 DO - 10.3390/jcm6010002 ID - Betensley2016 ER - TY - JOUR AU - King, T. E. AU - Pardo, A. AU - Selman, M. PY - 2011 DA - 2011// TI - Idiopathic pulmonary fibrosis JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(11)60052-4 DO - 10.1016/S0140-6736(11)60052-4 ID - King2011 ER - TY - JOUR AU - Wolters, P. J. AU - Collard, H. R. AU - Jones, K. D. PY - 2014 DA - 2014// TI - Pathogenesis of idiopathic pulmonary fibrosis JO - Annu Rev Pathol Mech Dis VL - 9 UR - https://doi.org/10.1146/annurev-pathol-012513-104706 DO - 10.1146/annurev-pathol-012513-104706 ID - Wolters2014 ER - TY - JOUR AU - Coward, W. R. AU - Saini, G. AU - Jenkins, G. PY - 2010 DA - 2010// TI - The pathogenesis of idiopathic pulmonary fibrosis JO - Ther Adv Respir Dis VL - 4 UR - https://doi.org/10.1177/1753465810379801 DO - 10.1177/1753465810379801 ID - Coward2010 ER - TY - JOUR AU - Evans, C. M. AU - Fingerlin, T. E. AU - Schwarz, M. I. AU - Lynch, D. AU - Kurche, J. AU - Warg, L. PY - 2016 DA - 2016// TI - Idiopathic pulmonary fibrosis: a genetic disease that involves Mucociliary dysfunction of the peripheral airways JO - Physiol Rev VL - 96 UR - https://doi.org/10.1152/physrev.00004.2016 DO - 10.1152/physrev.00004.2016 ID - Evans2016 ER - TY - STD TI - Zolak JS, de Andrade JA. Idiopathic pulmonary fibrosis [internet]. Costabel U, Crestani B, Wells AU, editors. Immunol Allergy Clin N Am. European Respiratory Society; 2012. ID - ref39 ER - TY - STD TI - Grimminger F, Günther A, Vancheri C. The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis. Eur Respir J. 2015;45:1426–33. ID - ref40 ER - TY - JOUR AU - Button, B. AU - Cai, L. -. H. AU - Ehre, C. AU - Kesimer, M. AU - Hill, D. B. AU - Sheehan, J. K. PY - 2012 DA - 2012// TI - A Periciliary brush promotes the lung health by separating the mucus layer from airway epithelia JO - Science (80- ) VL - 337 UR - https://doi.org/10.1126/science.1223012 DO - 10.1126/science.1223012 ID - Button2012 ER - TY - JOUR AU - Malli, F. AU - Koutsokera, A. AU - Paraskeva, E. AU - Zakynthinos, E. AU - Papagianni, M. AU - Makris, D. PY - 2013 DA - 2013// TI - Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0053658 DO - 10.1371/journal.pone.0053658 ID - Malli2013 ER - TY - JOUR AU - Hinz, B. PY - 2012 DA - 2012// TI - Mechanical aspects of lung fibrosis JO - Proc Am Thorac Soc VL - 9 UR - https://doi.org/10.1513/pats.201202-017AW DO - 10.1513/pats.201202-017AW ID - Hinz2012 ER - TY - JOUR AU - Maharaj, S. AU - Shimbori, C. AU - Kolb, M. PY - 2013 DA - 2013// TI - Fibrocytes in pulmonary fibrosis: a brief synopsis JO - Eur Respir Rev VL - 22 UR - https://doi.org/10.1183/09059180.00007713 DO - 10.1183/09059180.00007713 ID - Maharaj2013 ER - TY - JOUR AU - Wipff, P. J. AU - Rifkin, D. B. AU - Meister, J. J. AU - Myofibroblast, H. B. PY - 2007 DA - 2007// TI - Contraction activates latent TGF-β1 from the extracellular matrix JO - J Cell Biol VL - 179 UR - https://doi.org/10.1083/jcb.200704042 DO - 10.1083/jcb.200704042 ID - Wipff2007 ER - TY - JOUR AU - Scotton, C. J. AU - Chambers, R. C. PY - 2007 DA - 2007// TI - Molecular targets in pulmonary fibrosis: the myofibroblast in focus JO - Chest Am Coll Chest Physicians VL - 132 ID - Scotton2007 ER - TY - JOUR AU - Kotsianidis, I. AU - Nakou, E. AU - Bouchliou, I. AU - Tzouvelekis, A. AU - Spanoudakis, E. AU - Steiropoulos, P. PY - 2009 DA - 2009// TI - Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 179 UR - https://doi.org/10.1164/rccm.200812-1936OC DO - 10.1164/rccm.200812-1936OC ID - Kotsianidis2009 ER - TY - JOUR AU - Raghu, G. AU - Collard, H. R. AU - Egan, J. J. AU - Martinez, F. J. AU - Behr, J. AU - Brown, K. K. PY - 2011 DA - 2011// TI - An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management JO - Am J Respir Crit Care Med VL - 183 UR - https://doi.org/10.1164/rccm.2009-040GL DO - 10.1164/rccm.2009-040GL ID - Raghu2011 ER - TY - STD TI - Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of Nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071–82. The authors’ affiliations are listed in the Appendix. ID - ref49 ER - TY - JOUR AU - King, T. E. AU - Bradford, W. Z. AU - Castro-Bernardini, S. AU - Fagan, E. A. AU - Glaspole, I. AU - Glassberg, M. K. PY - 2014 DA - 2014// TI - A phase 3 trial of Pirfenidone in patients with idiopathic pulmonary fibrosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402582 DO - 10.1056/NEJMoa1402582 ID - King2014 ER - TY - JOUR AU - Wells, A. U. PY - 2016 DA - 2016// TI - Any fool can make a rule and any fool will mind it JO - BMC Med VL - 14 UR - https://doi.org/10.1186/s12916-016-0562-1 DO - 10.1186/s12916-016-0562-1 ID - Wells2016 ER - TY - JOUR AU - Raghu, G. AU - Rochwerg, B. AU - Zhang, Y. AU - Garcia, C. A. C. AU - Azuma, A. AU - Behr, J. PY - 2015 DA - 2015// TI - An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis: an update of the 2011 clinical practice guideline JO - Am J Respir Crit Care Med VL - 192 UR - https://doi.org/10.1164/rccm.201506-1063ST DO - 10.1164/rccm.201506-1063ST ID - Raghu2015 ER - TY - JOUR AU - Ryerson, C. J. AU - Urbania, T. H. AU - Richeldi, L. AU - Mooney, J. J. AU - Lee, J. S. AU - Jones, K. D. PY - 2013 DA - 2013// TI - Prevalence and prognosis of unclassifiable interstitial lung disease JO - Eur Respir J VL - 42 UR - https://doi.org/10.1183/09031936.00131912 DO - 10.1183/09031936.00131912 ID - Ryerson2013 ER - TY - JOUR AU - Dhooria, S. AU - Sehgal, I. S. AU - Aggarwal, A. N. AU - Behera, D. AU - Agarwal, R. PY - 2016 DA - 2016// TI - Diagnostic yield and safety of Cryoprobe Transbronchial lung biopsy in diffuse Parenchymal lung diseases: systematic review and meta-analysis JO - Respir Care VL - 61 UR - https://doi.org/10.4187/respcare.04488 DO - 10.4187/respcare.04488 ID - Dhooria2016 ER - TY - JOUR AU - Patel, N. M. AU - Borczuk, A. C. AU - Lederer, D. J. PY - 2016 DA - 2016// TI - Cryobiopsy in the diagnosis of interstitial lung disease: a step forward or back? JO - Am J Respir Crit Care Med VL - 193 UR - https://doi.org/10.1164/rccm.201511-2313ED DO - 10.1164/rccm.201511-2313ED ID - Patel2016 ER - TY - JOUR AU - Watadani, T. AU - Sakai, F. AU - Johkoh, T. AU - Noma, S. AU - Akira, M. AU - Fujimoto, K. PY - 2013 DA - 2013// TI - Interobserver variability in the CT assessment of honeycombing in the lungs JO - Radiology VL - 266 UR - https://doi.org/10.1148/radiol.12112516 DO - 10.1148/radiol.12112516 ID - Watadani2013 ER - TY - JOUR AU - Walsh, S. L. F. AU - Calandriello, L. AU - Sverzellati, N. AU - Wells, A. U. AU - Hansell, D. M. PY - 2016 DA - 2016// TI - Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT JO - Thorax VL - 71 UR - https://doi.org/10.1136/thoraxjnl-2015-207252 DO - 10.1136/thoraxjnl-2015-207252 ID - Walsh2016 ER - TY - JOUR AU - Yagihashi, K. AU - Huckleberry, J. AU - Colby, T. V. AU - Tazelaar, H. D. AU - Zach, J. AU - Sundaram, B. PY - 2016 DA - 2016// TI - Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia JO - Eur Respir J VL - 47 UR - https://doi.org/10.1183/13993003.01680-2015 DO - 10.1183/13993003.01680-2015 ID - Yagihashi2016 ER - TY - JOUR AU - Raghu, G. AU - Lynch, D. AU - Godwin, J. D. AU - Webb, R. AU - Colby, T. V. AU - Leslie, K. O. PY - 2014 DA - 2014// TI - Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70011-6 DO - 10.1016/S2213-2600(14)70011-6 ID - Raghu2014 ER - TY - JOUR AU - Raghu, G. AU - Wells, A. U. AU - Nicholson, A. G. AU - Richeldi, L. AU - Flaherty, K. R. AU - Le, M. F. PY - 2017 DA - 2017// TI - Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria JO - Am J Respir Crit Care Med VL - 195 UR - https://doi.org/10.1164/rccm.201602-0402OC DO - 10.1164/rccm.201602-0402OC ID - Raghu2017 ER - TY - STD TI - Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, et al. A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease: An International Working Group Perspective. Am. J. Respir. Crit. Care Med. 2017;rccm.201702-0400PP. ID - ref61 ER - TY - JOUR AU - Salisbury, M. L. AU - Xia, M. AU - Murray, S. AU - Bartholmai, B. J. AU - Kazerooni, E. A. AU - Meldrum, C. A. PY - 2016 DA - 2016// TI - Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: a cross sectional analysis in ILD patients undergoing lung tissue sampling JO - Respir Med VL - 118 UR - https://doi.org/10.1016/j.rmed.2016.07.016 DO - 10.1016/j.rmed.2016.07.016 ID - Salisbury2016 ER - TY - JOUR AU - Lynch, D. A. AU - Sverzellati, N. AU - Travis, W. D. AU - Brown, K. K. AU - Colby, T. V. AU - Galvin, J. R. PY - 2017 DA - 2017// TI - Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper JO - Lancet Respir Med VL - 2600 ID - Lynch2017 ER - TY - STD TI - Walsh SLF. Multidisciplinary evaluation of interstitial lung diseases: Current insights. Eur. Respir. Rev.. 2017 [cited 2017 Aug 3];26. ID - ref64 ER - TY - JOUR AU - Zhou, Y. AU - Chen, H. AU - Ambalavanan, N. AU - Liu, G. AU - Antony, V. B. AU - Ding, Q. PY - 2015 DA - 2015// TI - Noninvasive imaging of experimental lung fibrosis JO - Am J Respir Cell Mol Biol VL - 53 UR - https://doi.org/10.1165/rcmb.2015-0032TR DO - 10.1165/rcmb.2015-0032TR ID - Zhou2015 ER - TY - STD TI - Jones MG, Fabre A, Schneider P, Cinetto F, Sgalla G, Mavrogordato M, et al. Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis. JCI Insight [Internet]. 2016;1. ID - ref66 ER - TY - JOUR AU - Martinez, F. J. AU - Chisholm, A. AU - Collard, H. R. AU - Flaherty, K. R. AU - Myers, J. AU - Raghu, G. PY - 2017 DA - 2017// TI - The diagnosis of idiopathic pulmonary fibrosis: current and future approaches JO - Lancet Respir Med VL - 5 UR - https://doi.org/10.1016/S2213-2600(16)30325-3 DO - 10.1016/S2213-2600(16)30325-3 ID - Martinez2017 ER - TY - JOUR AU - Magnini, D. AU - Montemurro, G. AU - Iovene, B. AU - Tagliaboschi, L. AU - Gerardi, R. E. AU - Lo Greco, E. PY - 2017 DA - 2017// TI - Idiopathic pulmonary fibrosis: molecular Endotypes of fibrosis stratifying existing and emerging therapies JO - Respiration VL - 93 UR - https://doi.org/10.1159/000475780 DO - 10.1159/000475780 ID - Magnini2017 ER - TY - JOUR AU - Pankratz, D. G. AU - Choi, Y. AU - Imtiaz, U. AU - Fedorowicz, G. M. AU - Anderson, J. D. AU - Colby, T. V. PY - 2017 DA - 2017// TI - Usual interstitial pneumonia can be detected in transbronchial biopsies using machine learning JO - Ann Am Thorac Soc VL - 14 UR - https://doi.org/10.1513/AnnalsATS.201612-947OC DO - 10.1513/AnnalsATS.201612-947OC ID - Pankratz2017 ER - TY - JOUR AU - Fingerlin, T. E. AU - Murphy, E. AU - Zhang, W. AU - Peljto, A. L. AU - Brown, K. K. AU - Steele, M. P. PY - 2013 DA - 2013// TI - Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2609 DO - 10.1038/ng.2609 ID - Fingerlin2013 ER - TY - JOUR AU - Mushiroda, T. AU - Wattanapokayakit, S. AU - Takahashi, A. AU - Nukiwa, T. AU - Kudoh, S. AU - Ogura, T. PY - 2008 DA - 2008// TI - A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis JO - J Med Genet VL - 45 UR - https://doi.org/10.1136/jmg.2008.057356 DO - 10.1136/jmg.2008.057356 ID - Mushiroda2008 ER - TY - JOUR AU - Putman, R. K. AU - Rosas, I. O. AU - Genetics, H. G. M. PY - 2014 DA - 2014// TI - Early detection in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 189 UR - https://doi.org/10.1164/rccm.201312-2219PP DO - 10.1164/rccm.201312-2219PP ID - Putman2014 ER - TY - JOUR AU - Kan, M. AU - Shumyatcher, M. AU - Himes, B. E. PY - 2017 DA - 2017// TI - Using omics approaches to understand pulmonary diseases JO - Respir Res VL - 18 UR - https://doi.org/10.1186/s12931-017-0631-9 DO - 10.1186/s12931-017-0631-9 ID - Kan2017 ER - TY - JOUR AU - Maher, T. M. PY - 2013 DA - 2013// TI - PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery JO - Eur Respir Rev VL - 22 UR - https://doi.org/10.1183/09059180.00000913 DO - 10.1183/09059180.00000913 ID - Maher2013 ER - TY - JOUR AU - Maher, T. M. AU - Oballa, E. AU - Simpson, J. K. AU - Porte, J. AU - Habgood, A. AU - Fahy, W. A. PY - 2017 DA - 2017// TI - An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study JO - Lancet Respir Med VL - 5 UR - https://doi.org/10.1016/S2213-2600(17)30430-7 DO - 10.1016/S2213-2600(17)30430-7 ID - Maher2017 ER - TY - JOUR AU - Johnson, M. A. AU - Kwan, S. AU - Snell, N. J. AU - Nunn, A. J. AU - Darbyshire, J. H. AU - Turner-Warwick, M. PY - 1989 DA - 1989// TI - Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis JO - Thorax VL - 44 UR - https://doi.org/10.1136/thx.44.4.280 DO - 10.1136/thx.44.4.280 ID - Johnson1989 ER - TY - STD TI - Spagnolo P, Del Giovane C, Luppi F, Cerri S, Balduzzi S, Walters EH, et al. Non-steroid agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev. 2010:CD003134. ID - ref77 ER - TY - STD TI - Davies HRHR, Richeldi L, Walters EH. Immunomodulatory agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev. Department of Medicine, The Queen Elizabeth Hospital, Woodville Rd, Woodville, South Australia, Australia. 2003:CD003134. ID - ref78 ER - TY - JOUR AU - Raghu, G. AU - Anstrom, K. J. AU - King, T. E. AU - Lasky, J. A. AU - Martinez, F. J. PY - 2012 DA - 2012// TI - Prednisone, Azathioprine, and N -Acetylcysteine for pulmonary fibrosis JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1113354 DO - 10.1056/NEJMoa1113354 ID - Raghu2012 ER - TY - JOUR AU - King, T. E. AU - Bradford, W. Z. AU - Castro-Bernardini, S. AU - Fagan, E. A. AU - Glaspole, I. AU - Glassberg, M. K. PY - 2014 DA - 2014// TI - A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402582 DO - 10.1056/NEJMoa1402582 ID - King2014 ER - TY - JOUR AU - Hunninghake, G. M. PY - 2014 DA - 2014// TI - A new hope for idiopathic pulmonary fibrosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMe1403448 DO - 10.1056/NEJMe1403448 ID - Hunninghake2014 ER - TY - JOUR AU - Azuma, A. AU - Nukiwa, T. AU - Tsuboi, E. AU - Suga, M. AU - Abe, S. AU - Nakata, K. PY - 2005 DA - 2005// TI - Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 171 UR - https://doi.org/10.1164/rccm.200404-571OC DO - 10.1164/rccm.200404-571OC ID - Azuma2005 ER - TY - JOUR AU - Noble, P. W. AU - Albera, C. AU - Bradford, W. Z. AU - Costabel, U. AU - Glassberg, M. K. AU - Kardatzke, D. PY - 2011 DA - 2011// TI - Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60405-4 DO - 10.1016/S0140-6736(11)60405-4 ID - Noble2011 ER - TY - JOUR AU - Taniguchi, H. AU - Ebina, M. AU - Kondoh, Y. AU - Ogura, T. AU - Azuma, A. AU - Suga, M. PY - 2010 DA - 2010// TI - Pirfenidone in idiopathic pulmonary fibrosis JO - Eur Respir J VL - 35 UR - https://doi.org/10.1183/09031936.00005209 DO - 10.1183/09031936.00005209 ID - Taniguchi2010 ER - TY - JOUR AU - Costabel, U. AU - Albera, C. AU - Bradford, W. Z. AU - Hormel, P. AU - King, T. E. AU - Noble, P. W. PY - 2014 DA - 2014// TI - Analysis of lung function and survival in RECAP: an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis JO - Sarcoidosis Vasc Diffus Lung Dis VL - 31 ID - Costabel2014 ER - TY - JOUR AU - Maher, T. AU - Cottin, V. AU - Skoeld, M. AU - Tomassetti, S. AU - Azuma, A. AU - Giot, C. PY - 2014 DA - 2014// TI - S11 Pirfenidone post-authorisation safety registry (passport)-interim analysis of Ipf treatment JO - Thorax VL - 69 UR - https://doi.org/10.1136/thoraxjnl-2014-206260.17 DO - 10.1136/thoraxjnl-2014-206260.17 ID - Maher2014 ER - TY - JOUR AU - Bonella, F. AU - Wessendorf, T. E. AU - Costabel, U. PY - 2013 DA - 2013// TI - Klinische Erfahrungen mit Pirfenidon in der Therapie der idiopathischen Lungenfibrose JO - Dtsch Med Wochenschr VL - 138 UR - https://doi.org/10.1055/s-0032-1332930 DO - 10.1055/s-0032-1332930 ID - Bonella2013 ER - TY - JOUR AU - Loeh, B. AU - Drakopanagiotakis, F. AU - Bandelli, G. P. AU - Von Don Beck, D. AU - Tello, S. AU - Cordani, E. PY - 2015 DA - 2015// TI - Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 191 UR - https://doi.org/10.1164/rccm.201406-1106LE DO - 10.1164/rccm.201406-1106LE ID - Loeh2015 ER - TY - JOUR AU - Okuda, R. AU - Hagiwara, E. AU - Baba, T. AU - Kitamura, H. AU - Kato, T. AU - Ogura, T. PY - 2013 DA - 2013// TI - Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.06.011 DO - 10.1016/j.rmed.2013.06.011 ID - Okuda2013 ER - TY - JOUR AU - Oltmanns, U. AU - Kahn, N. AU - Palmowski, K. AU - Träger, A. AU - Wenz, H. AU - Heussel, C. P. PY - 2014 DA - 2014// TI - Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a german tertiary referral center for interstitial lung diseases JO - Respiration VL - 88 UR - https://doi.org/10.1159/000363064 DO - 10.1159/000363064 ID - Oltmanns2014 ER - TY - JOUR AU - Hilberg, F. AU - Roth, G. J. AU - Krssak, M. AU - Kautschitsch, S. AU - Sommergruber, W. AU - Tontsch-Grunt, U. PY - 2008 DA - 2008// TI - BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6307 DO - 10.1158/0008-5472.CAN-07-6307 ID - Hilberg2008 ER - TY - JOUR AU - Chaudhary, N. I. AU - Roth, G. J. AU - Hilberg, F. AU - Müller-Quernheim, J. AU - Prasse, A. AU - Zissel, G. PY - 2007 DA - 2007// TI - Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis JO - Eur Respir J VL - 29 UR - https://doi.org/10.1183/09031936.00152106 DO - 10.1183/09031936.00152106 ID - Chaudhary2007 ER - TY - JOUR AU - Richeldi, L. AU - Costabel, U. AU - Selman, M. AU - Kim, D. S. AU - Hansell, D. M. AU - Nicholson, A. G. PY - 2011 DA - 2011// TI - Efficacy of a tyrosine Kinase inhibitor in idiopathic pulmonary fibrosis JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1103690 DO - 10.1056/NEJMoa1103690 ID - Richeldi2011 ER - TY - JOUR AU - Bonella, F. AU - Kreuter, M. AU - Hagmeyer, L. AU - Neurohr, C. AU - Keller, C. AU - Kohlhaeufl, M. J. PY - 2016 DA - 2016// TI - Insights from the German compassionate use program of Nintedanib for the treatment of idiopathic pulmonary fibrosis JO - Respiration VL - 92 UR - https://doi.org/10.1159/000448288 DO - 10.1159/000448288 ID - Bonella2016 ER - TY - JOUR AU - Albera, C. AU - Costabel, U. AU - Fagan, E. A. AU - Glassberg, M. K. AU - Gorina, E. AU - Lancaster, L. PY - 2016 DA - 2016// TI - Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function JO - Eur Respir J VL - 48 UR - https://doi.org/10.1183/13993003.01966-2015 DO - 10.1183/13993003.01966-2015 ID - Albera2016 ER - TY - JOUR AU - Kolb, M. AU - Richeldi, L. AU - Behr, J. AU - Maher, T. M. AU - Tang, W. AU - Stowasser, S. PY - 2017 DA - 2017// TI - Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume JO - Thorax VL - 72 UR - https://doi.org/10.1136/thoraxjnl-2016-208710 DO - 10.1136/thoraxjnl-2016-208710 ID - Kolb2017 ER - TY - JOUR AU - Nathan, S. D. AU - Albera, C. AU - Bradford, W. Z. AU - Costabel, U. AU - du Bois, R. M. AU - Fagan, E. A. PY - 2016 DA - 2016// TI - Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis JO - Thorax VL - 71 UR - https://doi.org/10.1136/thoraxjnl-2015-207011 DO - 10.1136/thoraxjnl-2015-207011 ID - Nathan2016 ER - TY - JOUR AU - Wuyts, W. A. AU - Kolb, M. AU - Stowasser, S. AU - Stansen, W. AU - Huggins, J. T. AU - Raghu, G. PY - 2016 DA - 2016// TI - First data on efficacy and safety of Nintedanib in patients with idiopathic pulmonary fibrosis and forced vital capacity of ≤50 % of predicted value JO - Lung VL - 194 UR - https://doi.org/10.1007/s00408-016-9912-1 DO - 10.1007/s00408-016-9912-1 ID - Wuyts2016 ER - TY - JOUR AU - King, T. E. AU - Bradford, W. Z. AU - Castro-Bernardini, S. AU - Fagan, E. A. AU - Glaspole, I. AU - Glassberg, M. K. PY - 2014 DA - 2014// TI - A phase 3 trial of Pirfenidone in patients with idiopathic pulmonary fibrosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402582 DO - 10.1056/NEJMoa1402582 ID - King2014 ER - TY - JOUR AU - Milger, K. AU - Kneidinger, N. AU - Neurohr, C. AU - Reichenberger, F. AU - Behr, J. PY - 2015 DA - 2015// TI - Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF JO - Eur Respir J VL - 46 UR - https://doi.org/10.1183/13993003.00584-2015 DO - 10.1183/13993003.00584-2015 ID - Milger2015 ER - TY - JOUR AU - Wuyts, W. A. AU - Antoniou, K. M. AU - Borensztajn, K. AU - Costabel, U. AU - Cottin, V. AU - Crestani, B. PY - 2014 DA - 2014// TI - Combination therapy: the future of management for idiopathic pulmonary fibrosis? JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70232-2 DO - 10.1016/S2213-2600(14)70232-2 ID - Wuyts2014 ER - TY - JOUR AU - Ogura, T. AU - Taniguchi, H. AU - Azuma, A. AU - Inoue, Y. AU - Kondoh, Y. AU - Hasegawa, Y. PY - 2015 DA - 2015// TI - Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis JO - Eur Respir J VL - 45 UR - https://doi.org/10.1183/09031936.00198013 DO - 10.1183/09031936.00198013 ID - Ogura2015 ER - TY - JOUR AU - Lin, X. AU - Sime, P. J. AU - Xu, H. AU - Williams, M. A. AU - LaRussa, L. AU - Georas, S. N. PY - 2011 DA - 2011// TI - Yin Yang 1 is a novel regulator of pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 183 UR - https://doi.org/10.1164/rccm.201002-0232OC DO - 10.1164/rccm.201002-0232OC ID - Lin2011 ER - TY - JOUR AU - Flaherty, K. R. AU - Sussman, R. AU - Pesci, A. AU - Nunes, H. AU - Acosta, O. AU - Petzinger, U. AU - Stauffer, J. AU - Gilberg, F. AU - Bengus, M. L. L. PY - 2017 DA - 2017// TI - Safety of the combined use of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis (IPF): results from an interim analysis after 12 weeks JO - Am J Respir Crit Care Med VL - 195 ID - Flaherty2017 ER - TY - JOUR AU - Bajwah, S. AU - Higginson, I. J. AU - Ross, J. R. AU - Wells, A. U. AU - Birring, S. S. AU - Riley, J. PY - 2013 DA - 2013// TI - The palliative care needs for fibrotic interstitial lung disease: a qualitative study of patients, informal caregivers and health professionals JO - Palliat Med VL - 27 UR - https://doi.org/10.1177/0269216313497226 DO - 10.1177/0269216313497226 ID - Bajwah2013 ER - TY - JOUR AU - Lindell, K. O. AU - Olshansky, E. AU - Song, M. K. AU - Zullo, T. G. AU - Gibson, K. F. AU - Kaminski, N. PY - 2010 DA - 2010// TI - Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners JO - Hear Lung J Acute Crit Care VL - 39 UR - https://doi.org/10.1016/j.hrtlng.2009.08.005 DO - 10.1016/j.hrtlng.2009.08.005 ID - Lindell2010 ER - TY - JOUR AU - Lewis, D. AU - Scullion, J. PY - 2012 DA - 2012// TI - Palliative and end-of-life care for patients with idiopathic pulmonary fibrosis: challenges and dilemmas JO - Int J Palliat Nurs VL - 18 UR - https://doi.org/10.12968/ijpn.2012.18.7.331 DO - 10.12968/ijpn.2012.18.7.331 ID - Lewis2012 ER - TY - JOUR AU - Rajala, K. AU - Lehto, J. T. AU - Saarinen, M. AU - Sutinen, E. AU - Saarto, T. AU - Myllärniemi, M. PY - 2016 DA - 2016// TI - End-of-life care of patients with idiopathic pulmonary fibrosis JO - BMC Palliat Care VL - 15 UR - https://doi.org/10.1186/s12904-016-0158-8 DO - 10.1186/s12904-016-0158-8 ID - Rajala2016 ER - TY - JOUR AU - Lindell, K. O. AU - Liang, Z. AU - Hoffman, L. A. AU - Rosenzweig, M. Q. AU - Saul, M. I. AU - Pilewski, J. M. PY - 2015 DA - 2015// TI - Palliative care and location of death in decedents with idiopathic pulmonary fibrosis JO - Chest VL - 147 UR - https://doi.org/10.1378/chest.14-1127 DO - 10.1378/chest.14-1127 ID - Lindell2015 ER - TY - JOUR AU - Sampson, C. AU - Gill, B. H. AU - Harrison, N. K. AU - Nelson, A. AU - Byrne, A. PY - 2015 DA - 2015// TI - The care needs of patients with idiopathic pulmonary fibrosis and their carers (CaNoPy): results of a qualitative study JO - BMC Pulm Med VL - 15 UR - https://doi.org/10.1186/s12890-015-0145-5 DO - 10.1186/s12890-015-0145-5 ID - Sampson2015 ER - TY - JOUR AU - Bajwah, S. AU - Higginson, I. J. AU - Ross, J. R. AU - Wells, A. U. AU - Birring, S. S. AU - Riley, J. PY - 2013 DA - 2013// TI - The palliative care needs for fibrotic interstitial lung disease: a qualitative study of patients, informal caregivers and health professionals JO - Palliat Med VL - 27 UR - https://doi.org/10.1177/0269216313497226 DO - 10.1177/0269216313497226 ID - Bajwah2013 ER - TY - JOUR AU - Egan, J. J. PY - 2011 DA - 2011// TI - Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient JO - Eur Respir Rev VL - 20 UR - https://doi.org/10.1183/09059180.00001811 DO - 10.1183/09059180.00001811 ID - Egan2011 ER - TY - JOUR AU - Swigris, J. J. AU - Stewart, A. L. AU - Gould, M. K. AU - Wilson, S. R. PY - 2005 DA - 2005// TI - Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives JO - Health Qual Life Outcomes VL - 3 UR - https://doi.org/10.1186/1477-7525-3-61 DO - 10.1186/1477-7525-3-61 ID - Swigris2005 ER - TY - JOUR AU - Hope-Gill, B. D. M. AU - Hilldrup, S. AU - Davies, C. AU - Newton, R. P. AU - Study, H. N. K. A. PY - 2003 DA - 2003// TI - Of the cough reflex in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 168 UR - https://doi.org/10.1164/rccm.200304-597OC DO - 10.1164/rccm.200304-597OC ID - Hope-Gill2003 ER - TY - JOUR AU - Van Manen, M. J. G. AU - Birring, S. S. AU - Vancheri, C. AU - Cottin, V. AU - Renzoni, E. A. AU - Russell, A. M. PY - 2016 DA - 2016// TI - Cough in idiopathic pulmonary fibrosis JO - Eur Respir Rev VL - 25 UR - https://doi.org/10.1183/16000617.0090-2015 DO - 10.1183/16000617.0090-2015 ID - Van Manen2016 ER - TY - JOUR AU - Horton, M. R. AU - Santopietro, V. AU - Mathew, L. AU - Horton, K. M. AU - Polito, A. J. AU - Liu, M. C. PY - 2012 DA - 2012// TI - Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial JO - Ann Intern Med VL - 157 UR - https://doi.org/10.7326/0003-4819-157-6-201209180-00003 DO - 10.7326/0003-4819-157-6-201209180-00003 ID - Horton2012 ER - TY - STD TI - Azuma A, Taguchi Y, Ogura T, Ebina M, Taniguchi H, Kondoh Y, et al. Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment. Respir Res. 2011:12–143. ID - ref117 ER - TY - JOUR AU - Ong, K. C. AU - Wong, W. P. AU - Jailani, A. R. AU - Sew, S. AU - Ong, Y. Y. PY - 2001 DA - 2001// TI - Effects of a pulmonary rehabilitation programme on physiologic and psychosocial outcomes in patients with chronic respiratory disorders JO - Ann Acad Med Singap VL - 30 ID - Ong2001 ER - TY - JOUR AU - Swigris, J. J. AU - Fairclough, D. L. AU - Morrison, M. AU - Make, B. AU - Kozora, E. AU - Brown, K. K. PY - 2011 DA - 2011// TI - Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis JO - Respir Care VL - 56 UR - https://doi.org/10.4187/respcare.00939 DO - 10.4187/respcare.00939 ID - Swigris2011 ER - TY - STD TI - Holland AE, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev. 2008:CD006322. ID - ref120 ER - TY - STD TI - Gaunaurd IA, Gomez-Marin OW, Ramos CF, Sol CM, Cohen MI, Cahalin LP, et al. Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program. Respir Care. 2014;59:1872–9. Available from: ID - ref121 ER - TY - JOUR AU - Douglas, W. W. AU - Ryu, J. H. AU - Idiopathic, S. D. R. PY - 2000 DA - 2000// TI - Pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival JO - Am J Respir Crit Care Med VL - 161 UR - https://doi.org/10.1164/ajrccm.161.4.9907002 DO - 10.1164/ajrccm.161.4.9907002 ID - Douglas2000 ER - TY - JOUR AU - De Vries, J. AU - Kessels, B. L. J. AU - Drent, M. PY - 2001 DA - 2001// TI - Quality of life of idiopathic pulmonary fibrosis patients JO - Eur Respir J VL - 17 UR - https://doi.org/10.1183/09031936.01.17509540 DO - 10.1183/09031936.01.17509540 ID - De Vries2001 ER - TY - JOUR AU - Duck, A. AU - Spencer, L. G. AU - Bailey, S. AU - Leonard, C. AU - Ormes, J. AU - Caress, A. L. PY - 2015 DA - 2015// TI - Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis JO - J Adv Nurs VL - 71 UR - https://doi.org/10.1111/jan.12587 DO - 10.1111/jan.12587 ID - Duck2015 ER - TY - JOUR AU - Hofmann, S. G. AU - Sawyer, A. T. AU - Witt, A. A. AU - Oh, D. PY - 2010 DA - 2010// TI - The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review JO - J Consult Clin Psychol VL - 78 UR - https://doi.org/10.1037/a0018555 DO - 10.1037/a0018555 ID - Hofmann2010 ER - TY - JOUR AU - Pbert, L. AU - Madison, J. M. AU - Druker, S. AU - Olendzki, N. AU - Magner, R. AU - Reed, G. PY - 2012 DA - 2012// TI - Effect of mindfulness training on asthma quality of life and lung function: a randomised controlled trial JO - Thorax VL - 67 UR - https://doi.org/10.1136/thoraxjnl-2011-200253 DO - 10.1136/thoraxjnl-2011-200253 ID - Pbert2012 ER - TY - JOUR AU - Sgalla, G. AU - Cerri, S. AU - Ferrari, R. AU - Ricchieri, M. P. AU - Poletti, S. AU - Ori, M. PY - 2015 DA - 2015// TI - Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy JO - BMJ Open Respir Res VL - 2 UR - https://doi.org/10.1136/bmjresp-2014-000065 DO - 10.1136/bmjresp-2014-000065 ID - Sgalla2015 ER - TY - STD TI - Fulton BG, Ryerson CJ. Managing comorbidities in idiopathic pulmonary fibrosis. Int. J. Gen. Med. 2015. p. 309–18. ID - ref128 ER - TY - STD TI - Raghu G, Amatto VC, Behr J, Comorbidities SS. In idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015:1113–30. ID - ref129 ER - TY - JOUR AU - Hyldgaard, C. AU - Hilberg, O. AU - Bendstrup, E. PY - 2014 DA - 2014// TI - How does comorbidity influence survival in idiopathic pulmonary fibrosis? JO - Respir Med VL - 108 UR - https://doi.org/10.1016/j.rmed.2014.01.008 DO - 10.1016/j.rmed.2014.01.008 ID - Hyldgaard2014 ER - TY - STD TI - Cottin V. The impact of emphysema in pulmonary fibrosis. Eur Respir Rev. 2013:153–7. ID - ref131 ER - TY - JOUR AU - Ando, K. AU - Sekiya, M. AU - Tobino, K. AU - Takahashi, K. PY - 2013 DA - 2013// TI - Relationship between quantitative CT metrics and pulmonary function in combined pulmonary fibrosis and emphysema JO - Lung VL - 191 UR - https://doi.org/10.1007/s00408-013-9513-1 DO - 10.1007/s00408-013-9513-1 ID - Ando2013 ER - TY - STD TI - Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013;62(25 Suppl):D109–16 ID - ref133 ER - TY - JOUR AU - Lin, H. AU - Jiang, S. PY - 2015 DA - 2015// TI - Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone JO - J Thorac Dis VL - 7 ID - Lin2015 ER - TY - STD TI - Common VC. Pathways in idiopathic pulmonary fibrosis and cancer. Eur Respir Rev. 2013:265–72. ID - ref135 ER - TY - JOUR AU - Le Jeune, I. AU - Gribbin, J. AU - West, J. AU - Smith, C. AU - Cullinan, P. AU - Hubbard, R. PY - 2007 DA - 2007// TI - The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK JO - Respir Med VL - 101 UR - https://doi.org/10.1016/j.rmed.2007.07.012 DO - 10.1016/j.rmed.2007.07.012 ID - Le Jeune2007 ER - TY - JOUR AU - Suzuki, H. AU - Sekine, Y. AU - Yoshida, S. AU - Suzuki, M. AU - Shibuya, K. AU - Yonemori, Y. PY - 2011 DA - 2011// TI - Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography JO - Surg Today VL - 41 UR - https://doi.org/10.1007/s00595-010-4384-z DO - 10.1007/s00595-010-4384-z ID - Suzuki2011 ER - TY - JOUR AU - Nadrous, H. F. AU - Pellikka, P. A. AU - Krowka, M. J. AU - Swanson, K. L. AU - Chaowalit, N. AU - Decker, P. A. PY - 2005 DA - 2005// TI - Pulmonary hypertension in patients with idiopathic pulmonary fibrosis JO - Chest VL - 128 UR - https://doi.org/10.1378/chest.128.4.2393 DO - 10.1378/chest.128.4.2393 ID - Nadrous2005 ER - TY - JOUR AU - Kimura, M. AU - Taniguchi, H. AU - Kondoh, Y. AU - Kimura, T. AU - Kataoka, K. AU - Nishiyama, O. PY - 2013 DA - 2013// TI - Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis JO - Respiration VL - 85 UR - https://doi.org/10.1159/000345221 DO - 10.1159/000345221 ID - Kimura2013 ER - TY - JOUR AU - Shorr, A. F. AU - Wainright, J. L. AU - Cors, C. S. AU - Lettieri, C. J. AU - Pulmonary, N. S. D. PY - 2007 DA - 2007// TI - Hypertension in patients with pulmonary fibrosis awaiting lung transplant JO - Eur Respir J VL - 30 UR - https://doi.org/10.1183/09031936.00107206 DO - 10.1183/09031936.00107206 ID - Shorr2007 ER - TY - JOUR AU - King, T. E. AU - Behr, J. AU - Brown, K. K. AU - Du Bois, R. M. AU - Lancaster, L. AU - De Andrade, J. A. PY - 2008 DA - 2008// TI - BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 177 UR - https://doi.org/10.1164/rccm.200705-732OC DO - 10.1164/rccm.200705-732OC ID - King2008 ER - TY - JOUR AU - King, T. E. AU - Brown, K. K. AU - Raghu, G. AU - Du Bois, R. M. AU - Lynch, D. A. AU - Martinez, F. PY - 2011 DA - 2011// TI - BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 184 UR - https://doi.org/10.1164/rccm.201011-1874OC DO - 10.1164/rccm.201011-1874OC ID - King2011 ER - TY - STD TI - Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, et al. Treatment of idiopathic pulmonary fibrosis with Ambrisentan: a parallel, randomized trial. Ann Intern Med. 2013;158:641–9. Available from: ID - ref143 ER - TY - JOUR AU - Raghu, G. AU - Million-Rousseau, R. AU - Morganti, A. AU - Perchenet, L. AU - Behr, J. AU - Goh, N. PY - 2013 DA - 2013// TI - Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial JO - Eur Respir J VL - 42 UR - https://doi.org/10.1183/09031936.00104612 DO - 10.1183/09031936.00104612 ID - Raghu2013 ER - TY - JOUR AU - Zisman, D. A. AU - Schwarz, M. AU - Anstrom, K. J. AU - Collard, H. R. AU - Flaherty, K. R. AU - Hunninghake, G. W. PY - 2010 DA - 2010// TI - A controlled trial of Sildenafil in advanced idiopathic pulmonary fibrosis JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1002110 DO - 10.1056/NEJMoa1002110 ID - Zisman2010 ER - TY - JOUR AU - Collard, H. R. AU - Anstrom, K. J. AU - Schwarz, M. I. AU - Sildenafil, Z. D. A. PY - 2007 DA - 2007// TI - Improves walk distance in idiopathic pulmonary fibrosis JO - Chest VL - 131 UR - https://doi.org/10.1378/chest.06-2101 DO - 10.1378/chest.06-2101 ID - Collard2007 ER - TY - JOUR AU - Nathan, S. D. AU - King, C. S. PY - 2014 DA - 2014// TI - Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design? JO - Drug Des Devel Ther Dove Press VL - 8 UR - https://doi.org/10.2147/DDDT.S64907 DO - 10.2147/DDDT.S64907 ID - Nathan2014 ER - TY - JOUR AU - Mermigkis, C. AU - Chapman, J. AU - Golish, J. AU - Mermigkis, D. AU - Budur, K. AU - Kopanakis, A. PY - 2007 DA - 2007// TI - Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis JO - Lung VL - 185 UR - https://doi.org/10.1007/s00408-007-9004-3 DO - 10.1007/s00408-007-9004-3 ID - Mermigkis2007 ER - TY - STD TI - Milioli G, Bosi M, Poletti V, Tomassetti S, Grassi A, Riccardi S, et al. Sleep and respiratory sleep disorders in idiopathic pulmonary fibrosis. Sleep Med Rev 2014. p. 57–63. ID - ref149 ER - TY - JOUR AU - Bosi, M. AU - Milioli, G. AU - Fanfulla, F. AU - Tomassetti, S. AU - Ryu, J. H. AU - Parrino, L. PY - 2017 DA - 2017// TI - OSA and prolonged oxygen Desaturation during sleep are strong predictors of poor outcome in IPF JO - Lung VL - 195 UR - https://doi.org/10.1007/s00408-017-0031-4 DO - 10.1007/s00408-017-0031-4 ID - Bosi2017 ER - TY - JOUR AU - Mermigkis, C. AU - Bouloukaki, I. AU - Antoniou, K. AU - Papadogiannis, G. AU - Giannarakis, I. AU - Varouchakis, G. PY - 2015 DA - 2015// TI - Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis JO - Sleep Breath VL - 19 UR - https://doi.org/10.1007/s11325-014-1033-6 DO - 10.1007/s11325-014-1033-6 ID - Mermigkis2015 ER - TY - JOUR AU - Mermigkis, C. AU - Bouloukaki, I. AU - Antoniou, K. M. AU - Mermigkis, D. AU - Psathakis, K. AU - Giannarakis, I. PY - 2013 DA - 2013// TI - CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep? JO - Sleep Breath VL - 17 UR - https://doi.org/10.1007/s11325-013-0813-8 DO - 10.1007/s11325-013-0813-8 ID - Mermigkis2013 ER - TY - JOUR AU - Raghu, G. AU - Freudenberger, T. D. AU - Yang, S. AU - Curtis, J. R. AU - Spada, C. AU - Hayes, J. PY - 2006 DA - 2006// TI - High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis JO - Eur Respir J VL - 27 UR - https://doi.org/10.1183/09031936.06.00037005 DO - 10.1183/09031936.06.00037005 ID - Raghu2006 ER - TY - JOUR AU - Lee, J. S. AU - Ryu, J. H. AU - Elicker, B. M. AU - Lydell, C. P. AU - Jones, K. D. AU - Wolters, P. J. PY - 2011 DA - 2011// TI - Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 184 UR - https://doi.org/10.1164/rccm.201101-0138OC DO - 10.1164/rccm.201101-0138OC ID - Lee2011 ER - TY - JOUR AU - Nathan, S. D. AU - Basavaraj, A. AU - Reichner, C. AU - Shlobin, O. A. AU - Ahmad, S. AU - Kiernan, J. PY - 2010 DA - 2010// TI - Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis JO - Respir Med VL - 104 UR - https://doi.org/10.1016/j.rmed.2010.02.008 DO - 10.1016/j.rmed.2010.02.008 ID - Nathan2010 ER - TY - JOUR AU - Ponnuswamy, A. AU - Manikandan, R. AU - Sabetpour, A. AU - Keeping, I. M. PY - 2009 DA - 2009// TI - Between ischaemic heart disease and interstitial lung disease: a case-control study JO - Respir Med VL - 103 UR - https://doi.org/10.1016/j.rmed.2009.01.004 DO - 10.1016/j.rmed.2009.01.004 ID - Ponnuswamy2009 ER - TY - JOUR AU - Nathan, S. D. AU - Weir, N. AU - Shlobin, O. A. AU - Urban, B. A. AU - Curry, C. A. AU - Basavaraj, A. PY - 2011 DA - 2011// TI - The value of computed tomography scanning for the detection of coronary artery disease in patients with idiopathic pulmonary fibrosis JO - Respirology VL - 16 UR - https://doi.org/10.1111/j.1440-1843.2010.01919.x DO - 10.1111/j.1440-1843.2010.01919.x ID - Nathan2011 ER - TY - JOUR AU - Ryerson, C. J. AU - Arean, P. A. AU - Berkeley, J. AU - Carrieri-Kohlman, V. L. AU - Pantilat, S. Z. AU - Landefeld, C. S. PY - 2012 DA - 2012// TI - Depression is a common and chronic comorbidity in patients with interstitial lung disease JO - Respirology VL - 17 UR - https://doi.org/10.1111/j.1440-1843.2011.02122.x DO - 10.1111/j.1440-1843.2011.02122.x ID - Ryerson2012 ER - TY - JOUR AU - Akhtar, A. A. AU - Ali, M. A. AU - Smith, R. P. PY - 2013 DA - 2013// TI - Depression in patients with idiopathic pulmonary fibrosis JO - Chron Respir Dis VL - 10 UR - https://doi.org/10.1177/1479972313493098 DO - 10.1177/1479972313493098 ID - Akhtar2013 ER - TY - JOUR AU - Ryerson, C. J. AU - Berkeley, J. AU - Carrieri-Kohlman, V. L. AU - Pantilat, S. Z. AU - Landefeld, C. S. AU - Depression, C. H. R. PY - 2011 DA - 2011// TI - Functional status are strongly associated with dyspnea in interstitial lung disease JO - Chest VL - 139 UR - https://doi.org/10.1378/chest.10-0608 DO - 10.1378/chest.10-0608 ID - Ryerson2011 ER - TY - JOUR AU - Guiot, J. AU - Moermans, C. AU - Henket, M. AU - Corhay, J. -. L. AU - Louis, R. PY - 2017 DA - 2017// TI - Blood biomarkers in idiopathic pulmonary fibrosis JO - Lung VL - 195 UR - https://doi.org/10.1007/s00408-017-9993-5 DO - 10.1007/s00408-017-9993-5 ID - Guiot2017 ER - TY - JOUR AU - Varone, F. AU - Montemurro, G. AU - Macagno, F. AU - Calvello, M. AU - Conte, E. AU - Intini, E. PY - 2017 DA - 2017// TI - Investigational drugs for idiopathic pulmonary fibrosis JO - Expert Opin Investig Drugs VL - 26 UR - https://doi.org/10.1080/13543784.2017.1364361 DO - 10.1080/13543784.2017.1364361 ID - Varone2017 ER - TY - JOUR AU - Macagno, F. AU - Varone, F. AU - Leone, P. M. AU - Mari, P. V. AU - Panico, L. AU - Berardini, L. PY - 2017 DA - 2017// TI - New treatment directions for IPF: current status of ongoing and upcoming clinical trials JO - Expert Rev Respir Med VL - 11 UR - https://doi.org/10.1080/17476348.2017.1335601 DO - 10.1080/17476348.2017.1335601 ID - Macagno2017 ER - TY - JOUR AU - Raghu, G. AU - Richeldi, L. PY - 2017 DA - 2017// TI - Current approaches to the management of idiopathic pulmonary fibrosis JO - Respir Med VL - 129 UR - https://doi.org/10.1016/j.rmed.2017.05.017 DO - 10.1016/j.rmed.2017.05.017 ID - Raghu2017 ER -